nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant bisphosphonates for early-stage breast cancer
|
Brufsky, Adam |
|
2011 |
12 |
7 |
p. 610-611 2 p. |
artikel |
2 |
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
|
Gnant, Michael |
|
2011 |
12 |
7 |
p. 631-641 11 p. |
artikel |
3 |
2011 American Society of Clinical Oncology Annual Meeting
|
Benham, Laura |
|
2011 |
12 |
7 |
p. 627-628 2 p. |
artikel |
4 |
A new approach to cervical screening
|
Meijer, Chris JLM |
|
2011 |
12 |
7 |
p. 612-613 2 p. |
artikel |
5 |
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
|
Vitale, Alessandro |
|
2011 |
12 |
7 |
p. 654-662 9 p. |
artikel |
6 |
Breast Cancer Breakthroughs: Living Longer
|
Budd, Helen |
|
2011 |
12 |
7 |
p. 629- 1 p. |
artikel |
7 |
Cancer survivors: still room for improvement
|
The Lancet Oncology, |
|
2011 |
12 |
7 |
p. 609- 1 p. |
artikel |
8 |
Carcinogenicity of radiofrequency electromagnetic fields
|
Baan, Robert |
|
2011 |
12 |
7 |
p. 624-626 3 p. |
artikel |
9 |
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
|
Katki, Hormuzd A |
|
2011 |
12 |
7 |
p. 663-672 10 p. |
artikel |
10 |
Combination therapy in metastatic renal cell carcinoma
|
Heng, Daniel YC |
|
2011 |
12 |
7 |
p. 613-614 2 p. |
artikel |
11 |
Genetics of lung cancer susceptibility and COPD
|
Young, RP |
|
2011 |
12 |
7 |
p. 622-623 2 p. |
artikel |
12 |
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
|
Adams, Richard A |
|
2011 |
12 |
7 |
p. 642-653 12 p. |
artikel |
13 |
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
|
Wefel, Jeffrey S |
|
2011 |
12 |
7 |
p. 703-708 6 p. |
artikel |
14 |
Multiple myeloma and the road to personalised medicine
|
Russell, Stephen J |
|
2011 |
12 |
7 |
p. 617-619 3 p. |
artikel |
15 |
Nutrition and the Cancer Patient
|
Mourtzakis, Marina |
|
2011 |
12 |
7 |
p. 629-630 2 p. |
artikel |
16 |
Oesophageal cancer: who needs neoadjuvant therapy?
|
Walsh, Thomas N |
|
2011 |
12 |
7 |
p. 615-616 2 p. |
artikel |
17 |
Oncology perspectives: a call for essays
|
Grainger, Emma |
|
2011 |
12 |
7 |
p. 620- 1 p. |
artikel |
18 |
Optimising the lymphoma response criteria in the era of targeted therapy
|
Younes, Anas |
|
2011 |
12 |
7 |
p. 616-617 2 p. |
artikel |
19 |
Stenting as a bridge to surgery for colorectal cancer
|
Bridoux, Valerie |
|
2011 |
12 |
7 |
p. 621- 1 p. |
artikel |
20 |
Stenting as a bridge to surgery for colorectal cancer – Authors' reply
|
van Hooft, Jeanin E |
|
2011 |
12 |
7 |
p. 621-622 2 p. |
artikel |
21 |
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
|
Sjoquist, Katrin M |
|
2011 |
12 |
7 |
p. 681-692 12 p. |
artikel |
22 |
Survival benefit in hepatocellular carcinoma: when an innovative transplant strategy might benefit oncology
|
Sotiropoulos, Georgios C |
|
2011 |
12 |
7 |
p. 611-612 2 p. |
artikel |
23 |
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
|
Négrier, Sylvie |
|
2011 |
12 |
7 |
p. 673-680 8 p. |
artikel |
24 |
16th congress of the European Hematology Association
|
Ceschia, Audrey |
|
2011 |
12 |
7 |
p. 626- 1 p. |
artikel |
25 |
The Clink of Ice (Le Bruit des Glaçons)
|
Burki, Talha |
|
2011 |
12 |
7 |
p. 630- 1 p. |
artikel |
26 |
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
|
Jordheim, Lars Petter |
|
2011 |
12 |
7 |
p. 693-702 10 p. |
artikel |